Gene expression alterations in immune system pathways in the thymus after exposure to immunosuppressive Chemicals

Environmental Health Perspectives

Volumn 119, Issue 3, 2011, Pages 371-376

  Frawley, Rachel ^a   White Jr , Kimber ^b   Brown, Ronnetta ^b   Musgrove, Deborah ^b   Walker, Nigel ^a   Germolec, Dori ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

2,3,7,8 tetrachlorodibenzo p dioxin; Cyclophosphamide; Dexamethasone; Diethylstilbestrol; T cell; Thymus; Toxicogenomics

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CD28 ANTIGEN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DIETHYLSTILBESTROL; T LYMPHOCYTE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LINEAGE; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MAPPING; GENOME ANALYSIS; IMMUNOTOXICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THYMOCYTE; THYMUS; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; ANTIGENS, CD; ATROPHY; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DIETHYLSTILBESTROL; FEMALE; GENE EXPRESSION REGULATION; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE AGENTS; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TETRACHLORODIBENZODIOXIN; THYMUS GLAND; UP-REGULATION;

MUS;

EID: 79952341104     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1002358     Document Type: Article

References (48)

1. Ahmed SA. 2000. The immune system as a potential target for environmental estrogens (endocrine disrupters): a new emerging field. Toxicology 150:191-206.
2. Auerbach SS, Shah RR, Mav D, Smith CS, Walker NJ, Vallant MK, et al. 2010. Predicting the hepatocarcinogenic potential of alkenylbenzene flavoring agents using toxicogenomics and machine learning. Toxicol Appl Pharmacol 243:300-314.
3. Bai A, Hu H, Yeung M, Chen J. 2007. Kruppel-like factor 2 controls T-cell trafficking by activating L-selectin (CD62L) and sphingosine-1-phosphate receptor-1 transcription. J Immunol 178:7632-7639.
4. Bamezai A, Palliser D, Berezovskaya A, McGrew J, Higgins K, Lacy E, et al. 1995. Regulated expression of Ly-6A.2 is important for T-cell development. J Immunol 154:4233-4239.
5. Boverhof DR, Gollapudi BB, Hotchkiss JA, Osterloh-Quiroz M, Woolhiser MR. 2009. Evaluation of a toxicogenomic approach to the local lymph node assay (LLNA). Toxicol Sci 107:427-439.
6. Butts C, Shukair S, Duncan K, Harris C, Belyavskaya E, Sternberg E. 2007. Effects of dexamethasone on rat dendritic cell function. Horm Metab Res 39:404-412.
7. Camacho I, Singh N, Hegde V, Nagarkatti M, Nagarkatti P. 2005. Treatment of mice with 2,3,7,8-tetrachlorodibenzo-p-dioxin to aryl hydrocarbon receptor-dependent nuclear translocation of NF-kappaB and expression of Fas ligand in thymic stromal cells and consequent apoptosis in T cells. J Immunol 175:90-103.
8. Chaplin DD. 2010. Overview of the immune response. J Allergy Clin Immunol 125:S3-S23.
9. Cui Y, Paules R. 2010. Use of transcriptomics in understanding mechanisms of drug-induced toxicity. Pharmacogenomics 11:573-585.
10. Dean JH, Luster MI, Boorman GA, Lauer LD. 1982. Procedures available to examine the immunotoxicity of chemicals and drugs. Pharmacol Rev 34:137-148.
11. Dean JH, Luster MI, Munson AE, Amos H, eds. 1985. Immunotoxicology and Immunopharmacology. New York:Raven Press.
12. Evans VA, Cameron PU, Lewin SR. 2008. Human thymic dendritic cells: regulators of T-cell development in health and HIV-1 infection. Clin Immunol 126:1-12.
13. Fisher MT, Nagarkatti M, Nagarkatti PS. 2004. Combined screening of thymocytes using apoptosis-specific cDNA array and promoter analysis yields novel gene targets mediating TCDD-induced toxicity. Toxicol Sci 78:116-124.
14. Gould K, Shull J, Gorski J. 2000. DES action in the thymus: inhibition of cell proliferation and genetic variation. Mol Cell Endocrinol 170:31-39.
15. 1 generations of C57BL/6 mice: evidence of thymic regulation. Food Chem Toxicol 44:316-325.
16. Heinloth AN, Boorman GA, Foley JF, Flagler ND, Paules RS. 2007. Gene expression analysis offers unique advantages to histopathology in liver biopsy evaluations. Toxicol Pathol 35:276-300.
17. Heinloth AN, Irwin RD, Boorman GA, Nettesheim P, Fannin RD, Sieber SO, et al. 2004. Gene expression profiling of rat livers reveals indicators of potential adverse effects. Toxicol Sci 80:193-202.
18. Holladay SD. 1999. Prenatal immunotoxicant exposure and postnatal autoimmune disease. Environ Health Perspect 107:S687-S691.
19. Kerkvliet NI. 2002. Recent advances in understanding the mechanisms of TCDD immunotoxicity. Int Immunopharmacol 2:277-291.
20. Killeen N, Littman D. 1996. The regulation and function of the CD4 coreceptor during T-lymphocyte development. Curr Top Microbiol Immunol 205:89-106.
21. Kydd R, Lundberg K, Vremec D, Harris A, Shortman K. 1995. Intermediate steps in thymic positive selection. Generation of CD4-8+ T-cells in culture from CD4+8+, CD4int8+, and CD4+8int thymocytes with up-regulated levels of TCR-CD3. J Immunol 155:3806-3814.
22. Laskowitz D, Lee D, Schmechel D, Staats H. 2000. Altered immune responses in apolipoprotein E-deficient mice. J Lipid Res 41:613-620.
23. Lee JA, Hwang JA, Sung HN, Jeon CH, Gill BC, Youn HJ, et al. 2007. 2,3,7,8-Tetrachlorodibenzo-p-dioxin modulates functional differentiation of mouse bone marrow-derived dendritic cells: downregulation of RelB by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Lett 173:31-40.
24. Lowenberg M, Verhaar AP, van den Brink GR, Hommes DW. 2007. Glucorcorticoid signaling: a nongenomic mechanism for T-cell immunosuppression. Trends Mol Med 13:158-163.
25. Luebke RW, Chen DH, Dietert R, Yang Y, King M, Luster MI. 2006. The comparative immunotoxicity of five selected compounds following developmental or adult exposure. J Toxicol Environ Health B Crit Rev 9:1-26.
26. Luster MI, Dean JH, Boorman GA, Archer DL, Lauer L, Lawson LD, et al. 1981. The effects of orthophenylphenol, tris(2,3-dichloropropyl) phosphate, and cyclophosphamide on the immune system and host susceptibility of mice following subchronic exposure. Toxicol Appl Pharmacol 58:252-261.
27. Lynch R. 2000. Regulatory roles for FcgammaRIII (CD16) and FcgammaRII (CD32) in the development of T- and B-lineage lymphoid cells. J Leukoc Biol 67:279-284.
28. Marchetti MC, Di Marco B, Santini MC, Bartoli A, Delfino DV, Riccardi C. 2003. Dexamethasone-induced thymocyte apoptosis requires glucocorticoid receptor nuclear translocation but not mitochondrial membrane potential transition. Toxicol Lett 139:175-180.
29. Marodon G, Rocha B. 1994. Generation of mature T-cell populations in the thymus: CD4 or CD8 down-regulation occurs at different stages of thymocyte differentiation. Eur J Immunol 24:196-204.
30. Matthys P, Froyen G, Verdot L, Huang S, Sobis H, Van Damme J, et al. 1995. IFN-gamma receptor-deficient mice are hypersensitive to the anti-CD3-induced cytokine release syndrome and thymocyte apoptosis. Protective role of endogenous nitric oxide. J Immunol 155(8):3823-3829.
31. Matyszak M, Citterio S, Rescigno M, Ricciardi-Castagnoli P. 2000. Differential effects of corticosteroids during different stages of dendritic cell maturation. Eur J Immunol 30:1233-1242.
32. Pargmann D, Yücel R, Kosan C, Saba I, Klein-Hitpass L, Schimmer S, et al. 2007. Differential impact of the transcriptional repressor Gfi1 on mature CD4+ and CD8+ T lymphcyte function. Eur J Immunol 37:3551-3563.
33. Patterson RM, Germolec DR. 2006. Gene expression alterations in immune system pathways following exposure to immunosuppressive chemicals. Ann NY Acad Sci 1076:718-727.
34. Patterson RM, Walker NJ, White KJ, Brown R, Musgrove D, Harrison S, et al. 2006. Gene expression alterations in immune system pathways following exposure to immunosuppressive chemicals [Abstract 1750]. Toxicologist 90(1):359.
35. Rudd ML, Tua-Smith A, Straus DB. 2006. Lck SH3 domain function is required for T-cell receptor signals regulating thymocyte development. Mol Cell Biol 26:7892-7900.
36. Sasaki E, Yatabe Y, Hashimoto M, Yamashita Y, Hasegawa Y, Kojima H, et al. 2007. Development-dependent expression of cyclin D3 in precursor T-cell lymphoblastic leukemia/lymphoma. Pathol Int 57:53-59.
37. Shores E, Ono M, Kawabe T, Sommers C, Tran T, Lui K, et al. 1998. T-cell development in mice lacking all T-cell receptor zeta family members (zeta, eta, and FcepsilonRIgamma). J Exp Med 187:1093-1101.
38. Spencer J, Choy M, Hussell T, Papadaki L, Kington J, Isaacson P. 1992. Properties of thymic B cells. Immunology 75:596-600.
39. Squier MK, Cohen JJ. 1997. Calpain, an upstream regulator of thymocyte apoptosis. J Immunol 158:3690-3697.
40. Stremmel C, Siebenhaar R, Croner R, Reingruber B, Slavin AJ, Hohenberger W. 2005. Characterization of gene expression profiles of T-cells during antitumor response. Int J Colorectal Dis 20:485-493.
41. van Vliet E, Melis M, van Ewijk W. 1986. The influence of dexamethasone treatment on the lymphoid and stromal composition of the mouse thymus: a flow cytometric and immunohistochemical analysis. Cell Immunol 103:229-240.
42. Vorderstrasse B, Dearstyne E, Kerkvliet N. 2003. Influence of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the antigen-presenting activity of dendritic cells. Toxicol Sci 72:103-112.
43. Wang G, Cai L. 1999. Relatively low-dose cyclophosphamide is likely to induce apoptotic cell death in rat thymus through Fas/Fas ligand pathway. Mutat Res 427:125-133.
44. Wei W, Clarke C, Somers G, Cresswell K, Loveland K, Trapani J, et al. 2003. Expression of IFI 16 in epithelial cells and lymphoid tissues. Histochem Cell Biol 119:45-54.
45. Williams O, Gil-Gómez G, Norton T, Kioussis D, Brady HJ. 2000. Activation of Cdk2 is a requirement for antigen-mediated thymic negative selection. Eur J Immunol 30:709-713.
46. Willinger T, Freeman T, Herbert M, Hasegawa H, McMichael A, Callan M. 2006. Human naive CD8 T cells down-regulate expression of the WNT pathway transcription factors lymphoid enhancer binding factor-1 and transcription factor-7 (T-cell factor-1) following antigen encounter in vitro and in vivo. J Immunol 176:1439-1446.
47. Yucel R, Karsunky H, Klein-Hitpass L, Moroy T. 2003. The transcriptional repressor Gfi1 affects development of early, uncommitted c-Kit+ T-cell progenitors and CD4/CD8 lineage decision in the thymus. J Exp Med 197:831-844.
48. Zhou Z, Gordon SA, Kim YM, Hoffman RA, Chen Y, Zhang XR, et al. 2000. Nitric oxide induces thymocyte apoptosis via a caspase-1-dependent mechanism. J Immunol 165:1252-1258.